# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 16, "Pediatr Diabetes", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasJournal> \"Pediatr Diabetes\"."
1, PublicationYear, 19, 23, "2008", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasPublicationYear> \"2008\"."
2, PublicationYear, 111, 115, "2008", "", 
77, Title, 125, 249, "Short - term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance .", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasTitle> \"Short - term metabolic and cardiovascular effects of metformin in markedly obese adolescents with normal glucose tolerance .\"."
3, Metformin, 178, 187, "metformin", "", 
4, Precondition, 191, 247, "markedly obese adolescents with normal glucose tolerance", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasPrecondition> \"markedly obese adolescents with normal glucose tolerance\"."
5, Author, 250, 260, "Burgert TS", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Burgert TS\"."
6, Author, 269, 277, "Duran EJ", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Duran EJ\"."
7, Author, 280, 297, "Goldberg - Gell R", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Goldberg - Gell R\"."
8, Author, 300, 308, "Dziura J", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Dziura J\"."
9, Author, 311, 320, "Yeckel CW", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Yeckel CW\"."
10, Author, 323, 329, "Katz S", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Katz S\"."
11, Author, 332, 345, "Tamborlane WV", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Tamborlane WV\"."
12, Author, 348, 356, "Caprio S", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasAuthor> \"Caprio S\"."
13, USA, 473, 476, "USA", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
19, ObjectiveDescription, 520, 702, "Although metformin ( MET ) is an insulin sensitizer currently used as an adjunct to the treatment of some of the complications of childhood obesity besides type 2 diabetes mellitus ,", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasObjectiveDescription> \"Although metformin ( MET ) is an insulin sensitizer currently used as an adjunct to the treatment of some of the complications of childhood obesity besides type 2 diabetes mellitus ,\"."
14, Metformin, 529, 538, "metformin", "", 
15, Metformin, 541, 544, "MET", "", 
16, Insulin, 553, 560, "insulin", "", 
17, Type2Diabetes, 676, 700, "type 2 diabetes mellitus", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
148, ObjectiveDescription, 703, 837, "few studies have comprehensively examined its metabolic and clinical effects in obese children with normal glucose tolerance ( NGT ) .", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasObjectiveDescription> \"few studies have comprehensively examined its metabolic and clinical effects in obese children with normal glucose tolerance ( NGT ) .\"."
18, Precondition, 783, 835, "obese children with normal glucose tolerance ( NGT )", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasPrecondition> \"obese children with normal glucose tolerance ( NGT )\"."
20, Duration, 873, 882, "4 - month", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasCTduration> \"4 - month\"."
21, DoubleBlind, 883, 897, "double - blind", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
22, NumberPatientsCT, 916, 918, "28", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasNumberPatientsCT> \"28\"."
119906, Precondition, 919, 991, "obese [ mean body mass index ( BMI ) : 40 . 3 + / - 5 . 7 kg / m ( 2 ) ]", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasPrecondition> \"obese [ mean body mass index ( BMI ) : 40 . 3 + / - 5 . 7 kg / m ( 2 ) ]\"."
99, Mean, 927, 931, "mean", "", 
23, BMI, 932, 947, "body mass index", "", 
24, BMI, 950, 953, "BMI", "", 
25, Kg_per_squareMeter, 977, 989, "kg / m ( 2 )", "", "<http://ctro/data#Endpoint_110088> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg_per_squareMeter>."
26, Insulin, 994, 1001, "insulin", "", 
119908, Precondition, 994, 1085, "insulin - resistant [ homeostasis model assessment - insulin resistance : 7 . 6 + / - 2 . 8", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasPrecondition> \"insulin - resistant [ homeostasis model assessment - insulin resistance : 7 . 6 + / - 2 . 8\"."
27, Insulin, 1047, 1054, "insulin", "", 
119909, Precondition, 1090, 1200, "whole body insulin sensitivity index ( WBISI ) : 1 . 5 + / - 0 . 7 ] adolescents ( age 15 . 0 + / - 1 . 3 yr )", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasPrecondition> \"whole body insulin sensitivity index ( WBISI ) : 1 . 5 + / - 0 . 7 ] adolescents ( age 15 . 0 + / - 1 . 3 yr )\"."
28, Insulin, 1101, 1108, "insulin", "", 
29, AvgAge, 1177, 1183, "15 . 0", "", "<http://ctro/data#Population_110002> <http://ctro/data#hasAvgAge> \"15 . 0\"."
30, Randomized, 1201, 1211, "randomized", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
31, Metformin, 1215, 1218, "MET", "", "<http://ctro/data#Medication_110047> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
32, NumberPatientsArm, 1225, 1227, "15", "", "<http://ctro/data#Arm_110017> <http://ctro/data#hasNumberPatientsArm> \"15\"."
33, DoseValue, 1235, 1239, "1500", "", "<http://ctro/data#Medication_110047> <http://ctro/data#hasDoseValue> \"1500\"."
34, mg, 1240, 1242, "mg", "", "<http://ctro/data#Medication_110047> <http://ctro/data#hasDoseUnit> <http://ctro/data#mg>."
35, Frequency, 1243, 1248, "daily", "", "<http://ctro/data#Intervention_110035> <http://ctro/data#hasFrequency> \"daily\"."
36, Placebo, 1254, 1261, "placebo", "", "<http://ctro/data#Medication_110054> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
37, NumberPatientsArm, 1268, 1270, "13", "", "<http://ctro/data#Arm_110026> <http://ctro/data#hasNumberPatientsArm> \"13\"."
39, Metformin, 1304, 1307, "MET", "", 
40, Metformin, 1329, 1332, "MET", "", 
41, BMI, 1375, 1378, "BMI", "", "<http://ctro/data#Endpoint_110088> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BMI>."
43, PValueChangeValue, 1381, 1391, "p = 0 . 02", "", "<http://ctro/data#Outcome_110120> <http://ctro/data#hasPValueChangeValue> \"p = 0 . 02\"."
42, EndPointDescription, 1425, 1441, "subcutaneous fat", "", "<http://ctro/data#EndPointDescription_110013> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_110012> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_110013>."
44, PValueChangeValue, 1444, 1454, "p = 0 . 03", "", "<http://ctro/data#Outcome_110061> <http://ctro/data#hasPValueChangeValue> \"p = 0 . 03\"."
71, SubGroupDescription, 1476, 1497, "deep subcutaneous fat", "", "<http://ctro/data#Outcome_110093> <http://ctro/data#hasSubGroupDescription> \"deep subcutaneous fat\"."
45, PValueChangeValue, 1500, 1510, "p = 0 . 04", "", "<http://ctro/data#Outcome_110093> <http://ctro/data#hasPValueChangeValue> \"p = 0 . 04\"."
46, MeasurementDevice, 1528, 1554, "magnetic resonance imaging", "", "<http://ctro/data#MeasurementDevice_110016> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_110012> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_110016>."
47, Metformin, 1580, 1583, "MET", "", 
48, RelativeChangeValue, 1596, 1598, "35", "", "<http://ctro/data#Outcome_110152> <http://ctro/data#hasRelativeChangeValue> \"35\"."
124, Percentage, 1599, 1600, "%", "", 
51, ObservedResult, 1601, 1612, "improvement", "", "<http://ctro/data#Outcome_110152> <http://ctro/data#hasObservedResult> \"improvement\"."
49, EndPointDescription, 1616, 1635, "insulin sensitivity", "", "<http://ctro/data#EndPointDescription_110148> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_110147> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_110148>."
50, EndPointDescription, 1638, 1643, "WBISI", "", 
52, Placebo, 1664, 1671, "placebo", "", 
53, PvalueDiff, 1680, 1691, "p = 0 . 008", "", "<http://ctro/data#DiffBetweenGroups_110206> <http://ctro/data#hasPvalueDiff> \"p = 0 . 008\"."
55, EndPointDescription, 1773, 1792, "insulin sensitivity", "", 
54, PvalueDiff, 1795, 1805, "p = 0 . 09", "", 
64, ObservedResult, 1816, 1835, "there was no change", "", "<http://ctro/data#Outcome_110230> <http://ctro/data#hasObservedResult> \"there was no change\". <http://ctro/data#Outcome_110257> <http://ctro/data#hasObservedResult> \"there was no change\"."
56, EndPointDescription, 1839, 1861, "inflammatory cytokines", "", "<http://ctro/data#EndPointDescription_110216> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_110215> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_110216>."
57, EndPointDescription, 1865, 1881, "lipid parameters", "", "<http://ctro/data#EndPointDescription_110221> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_110220> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_110221>."
58, EndPointDescription, 1884, 1907, "cardiovascular function", "", "<http://ctro/data#EndPointDescription_110226> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_110225> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_110226>."
134, ObservedResult, 1958, 1966, "improved", "", "<http://ctro/data#Outcome_110284> <http://ctro/data#hasObservedResult> \"improved\"."
59, Metformin, 1972, 1975, "MET", "", 
135, ObservedResult, 1980, 1988, "worsened", "", "<http://ctro/data#Outcome_110311> <http://ctro/data#hasObservedResult> \"worsened\"."
60, Placebo, 1992, 1999, "placebo", "", 
61, PvalueDiff, 2002, 2012, "p = 0 . 03", "", "<http://ctro/data#DiffBetweenGroups_110338> <http://ctro/data#hasPvalueDiff> \"p = 0 . 03\"."
141, ConclusionComment, 2030, 2225, "Short - term use of MET is well tolerated by obese children with NGT and has a beneficial effect on BMI and autonomic control of the heart as well as a trend toward improved insulin sensitivity .", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasConclusionComment> \"Short - term use of MET is well tolerated by obese children with NGT and has a beneficial effect on BMI and autonomic control of the heart as well as a trend toward improved insulin sensitivity .\"."
63, Metformin, 2050, 2053, "MET", "", 
66, BMI, 2130, 2133, "BMI", "", 
68, EndPointDescription, 2138, 2168, "autonomic control of the heart", "", 
67, EndPointDescription, 2204, 2223, "insulin sensitivity", "", 
143, ConclusionComment, 2226, 2357, "Thus , long - term treatment with MET may provide a means to ameliorate the cardio - metabolic consequences of adolescent obesity .", "", "<http://ctro/data#ClinicalTrial_109983> <http://ctro/data#hasConclusionComment> \"Thus , long - term treatment with MET may provide a means to ameliorate the cardio - metabolic consequences of adolescent obesity .\"."
69, Metformin, 2260, 2263, "MET", "", 
70, PMID, 2418, 2426, "18761646", "", "<http://ctro/data#Publication_109969> <http://ctro/data#hasPMID> \"18761646\"."
